Skip to main content
Top
Published in: Respiratory Research 1/2010

Open Access 01-12-2010 | Research

Colour of sputum is a marker for bacterial colonisation in chronic obstructive pulmonary disease

Authors: Marc Miravitlles, Alicia Marín, Eduard Monsó, Sara Vilà, Cristian de la Roza, Ramona Hervás, Cristina Esquinas, Marian García, Laura Millares, Josep Morera, Antoni Torres

Published in: Respiratory Research | Issue 1/2010

Login to get access

Abstract

Background

Bacterial colonisation in chronic obstructive pulmonary disease (COPD) contributes to airway inflammation and modulates exacerbations. We assessed risk factors for bacterial colonisation in COPD.

Methods

Patients with stable COPD consecutively recruited over 1 year gave consent to provide a sputum sample for microbiologic analysis. Bronchial colonisation by potentially pathogenic microorganisms (PPMs) was defined as the isolation of PPMs at concentrations of ≥102 colony-forming units (CFU)/mL on quantitative bacterial culture. Colonised patients were divided into high (>105 CFU/mL) or low (<105 CFU/mL) bacterial load.

Results

A total of 119 patients (92.5% men, mean age 68 years, mean forced expiratory volume in one second [FEV1] [% predicted] 46.4%) were evaluated. Bacterial colonisation was demonstrated in 58 (48.7%) patients. Patients with and without bacterial colonisation showed significant differences in smoking history, cough, dyspnoea, COPD exacerbations and hospitalisations in the previous year, and sputum colour. Thirty-six patients (62% of those colonised) had a high bacterial load. More than 80% of the sputum samples with a dark yellow or greenish colour yielded PPMs in culture. In contrast, only 5.9% of white and 44.7% of light yellow sputum samples were positive (P < 0.001). Multivariate analysis showed an increased degree of dyspnoea (odds ratio [OR] = 2.63, 95% confidence interval [CI] 1.53-5.09, P = 0.004) and a darker sputum colour (OR = 4.11, 95% CI 2.30-7.29, P < 0.001) as factors associated with the presence of PPMs in sputum.

Conclusions

Almost half of our population of ambulatory moderate to very severe COPD patients were colonised with PPMs. Patients colonised present more severe dyspnoea, and a darker colour of sputum allows identification of individuals more likely to be colonised.
Literature
1.
go back to reference Miravitlles M, Murio C, Guerrero T, Gisbert R: Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest 2002, 121:1449–1455.CrossRefPubMed Miravitlles M, Murio C, Guerrero T, Gisbert R: Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest 2002, 121:1449–1455.CrossRefPubMed
2.
go back to reference Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA: Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002, 57:847–852.CrossRefPubMedPubMedCentral Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA: Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002, 57:847–852.CrossRefPubMedPubMedCentral
3.
go back to reference Soler-Cataluña JJ, Martínez-García MA, Román P, Salcedo E, Navarro M, Ochando R: Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005, 60:925–931.CrossRefPubMedPubMedCentral Soler-Cataluña JJ, Martínez-García MA, Román P, Salcedo E, Navarro M, Ochando R: Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005, 60:925–931.CrossRefPubMedPubMedCentral
4.
go back to reference Monsó E, Ruiz J, Rosell A, Manterola J, Fiz J, Morera J, Ausina V: Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med 1995, 152:1316–1320.CrossRefPubMed Monsó E, Ruiz J, Rosell A, Manterola J, Fiz J, Morera J, Ausina V: Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med 1995, 152:1316–1320.CrossRefPubMed
5.
go back to reference Rosell A, Monsó E, Soler N, Torres F, Angrill J, Riise G, Zalacaín R, Morera J, Torres A: Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. Arch Intern Med 2005, 165:891–897.CrossRefPubMed Rosell A, Monsó E, Soler N, Torres F, Angrill J, Riise G, Zalacaín R, Morera J, Torres A: Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. Arch Intern Med 2005, 165:891–897.CrossRefPubMed
6.
go back to reference Miravitlles M: Exacerbations of chronic obstructive pulmonary disease: when are bacteria important? Eur Respir J 2002,20(Suppl 36):1s-11s. Miravitlles M: Exacerbations of chronic obstructive pulmonary disease: when are bacteria important? Eur Respir J 2002,20(Suppl 36):1s-11s.
7.
go back to reference Papi A, Bellettato CM, Braccioni F, Romagnoli M, Casolari P, Caramori G, Fabbri LM, Johnston SL: Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 2006, 173:1114–1121.CrossRefPubMed Papi A, Bellettato CM, Braccioni F, Romagnoli M, Casolari P, Caramori G, Fabbri LM, Johnston SL: Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 2006, 173:1114–1121.CrossRefPubMed
8.
go back to reference Hill AT, Campbell EJ, Hill SL, Bayley DL, Stockley RA: Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med 2000, 109:288–295.CrossRefPubMed Hill AT, Campbell EJ, Hill SL, Bayley DL, Stockley RA: Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med 2000, 109:288–295.CrossRefPubMed
9.
go back to reference Patel IS, Seemungal TA, Wilks M, Lloyd-Owen SJ, Wedzicha JA: Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 2002, 57:759–764.CrossRefPubMedPubMedCentral Patel IS, Seemungal TA, Wilks M, Lloyd-Owen SJ, Wedzicha JA: Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 2002, 57:759–764.CrossRefPubMedPubMedCentral
10.
go back to reference Wilkinson TM, Patel IS, Wilks M, Donaldson GC, Wedzicha JA: Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003, 167:1090–1095.CrossRefPubMed Wilkinson TM, Patel IS, Wilks M, Donaldson GC, Wedzicha JA: Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003, 167:1090–1095.CrossRefPubMed
11.
go back to reference Zalacain R, Sobradillo V, Amilibia J, Barrón J, Achótegui V, Pijoan JI, Llorente JL: Predisposing factors to bacterial colonisation in chronic obstructive pulmonary disease. Eur Respir J 1999, 13:343–348.CrossRefPubMed Zalacain R, Sobradillo V, Amilibia J, Barrón J, Achótegui V, Pijoan JI, Llorente JL: Predisposing factors to bacterial colonisation in chronic obstructive pulmonary disease. Eur Respir J 1999, 13:343–348.CrossRefPubMed
12.
go back to reference Monsó E, Rosell A, Bonet G, Manterola J, Cardona PJ, Ruiz J, Morera J: Risk factors for lower airway bacterial colonisation in chronic bronchitis. Eur Respir J 1999, 13:338–342.CrossRefPubMed Monsó E, Rosell A, Bonet G, Manterola J, Cardona PJ, Ruiz J, Morera J: Risk factors for lower airway bacterial colonisation in chronic bronchitis. Eur Respir J 1999, 13:338–342.CrossRefPubMed
13.
go back to reference Miravitlles M, Marín A, Monsó E, Vilà S, de la Roza C, Hervás R, Esquinas C, García M, Millares L, Morera J, Torres A: Efficacy of moxifloxacin in the treatment of bronchial colonisation in COPD. Eur Respir J 2009, 34:1066–1071.CrossRefPubMed Miravitlles M, Marín A, Monsó E, Vilà S, de la Roza C, Hervás R, Esquinas C, García M, Millares L, Morera J, Torres A: Efficacy of moxifloxacin in the treatment of bronchial colonisation in COPD. Eur Respir J 2009, 34:1066–1071.CrossRefPubMed
14.
go back to reference Sanchis J y Grupo de trabajo de la SEPAR: Normativa para la práctica de la espirometría forzada. Arch Bronconeumol 1989, 25:132–142.CrossRef Sanchis J y Grupo de trabajo de la SEPAR: Normativa para la práctica de la espirometría forzada. Arch Bronconeumol 1989, 25:132–142.CrossRef
15.
go back to reference Pin I, Gibson PG, Kolendowicz R, Girgis-Gabardo A, Denburg JA, Hargreave FE, Dolovich J: Use induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992, 47:25–29.CrossRefPubMedPubMedCentral Pin I, Gibson PG, Kolendowicz R, Girgis-Gabardo A, Denburg JA, Hargreave FE, Dolovich J: Use induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992, 47:25–29.CrossRefPubMedPubMedCentral
16.
go back to reference Pizzichini E, Pizzichini MM, Efthimiadis A, Evans S, Morris MM, Squillace D, Gleich GJ, Dolovich J, Hargreave FE: Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996, 154:308–317.CrossRefPubMed Pizzichini E, Pizzichini MM, Efthimiadis A, Evans S, Morris MM, Squillace D, Gleich GJ, Dolovich J, Hargreave FE: Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996, 154:308–317.CrossRefPubMed
17.
go back to reference Aaron SD, Angel JB, Lunau M, Wright K, Fex C, Le Saux N, Dales RE: Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001, 163:349–355.CrossRefPubMed Aaron SD, Angel JB, Lunau M, Wright K, Fex C, Le Saux N, Dales RE: Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001, 163:349–355.CrossRefPubMed
18.
go back to reference Angrill J, Agustí C, de Celis R, Rañó A, Gonzalez J, Solé T, Xaubet A, Rodriguez-Roisin R, Torres A: Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors. Thorax 2002, 57:15–19.CrossRefPubMedPubMedCentral Angrill J, Agustí C, de Celis R, Rañó A, Gonzalez J, Solé T, Xaubet A, Rodriguez-Roisin R, Torres A: Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors. Thorax 2002, 57:15–19.CrossRefPubMedPubMedCentral
19.
go back to reference Cabello H, Torres A, Celis R, El-Ebiary M, Puig de la Bellacasa J, Xaubet A, González J, Agustí C, Soler N: Bacterial colonisation of distal airways in healthy subjects and chronic lung disease: a bronchoscopic study. Eur Respir J 1997, 10:1137–1144.CrossRefPubMed Cabello H, Torres A, Celis R, El-Ebiary M, Puig de la Bellacasa J, Xaubet A, González J, Agustí C, Soler N: Bacterial colonisation of distal airways in healthy subjects and chronic lung disease: a bronchoscopic study. Eur Respir J 1997, 10:1137–1144.CrossRefPubMed
20.
go back to reference Weinreich UM, Korsgaard J: Bacterial colonisation of lower airways in health and chronic lung disease. Clinical Respiratory Journal 2008, 2:116–122.CrossRefPubMed Weinreich UM, Korsgaard J: Bacterial colonisation of lower airways in health and chronic lung disease. Clinical Respiratory Journal 2008, 2:116–122.CrossRefPubMed
21.
go back to reference Soler N, Ewig S, Torres A, Filella X, Gonzalez J, Xaubet A: Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J 1999, 14:1015–1022.CrossRefPubMed Soler N, Ewig S, Torres A, Filella X, Gonzalez J, Xaubet A: Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J 1999, 14:1015–1022.CrossRefPubMed
22.
go back to reference Marin A, García M, Badorrey I, Sabrià M, Morera J, Monsó E: Spontaneous sputum production as a marker of bacterial colonisation in stable COPD. Eur Respir J 2005,26(Suppl 49):232. abstract Marin A, García M, Badorrey I, Sabrià M, Morera J, Monsó E: Spontaneous sputum production as a marker of bacterial colonisation in stable COPD. Eur Respir J 2005,26(Suppl 49):232. abstract
23.
go back to reference Sethi S, Maloney J, Grove L, Wrona C, Berenson CS: Airway inflammation and bronchial bacterial colonisation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006, 173:991–998.CrossRefPubMedPubMedCentral Sethi S, Maloney J, Grove L, Wrona C, Berenson CS: Airway inflammation and bronchial bacterial colonisation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006, 173:991–998.CrossRefPubMedPubMedCentral
24.
go back to reference Sapey E, Bayley D, Ahmad A, Newbold P, Snell N, Stockley RA: Inter-relationships between inflammatory markers in patients with stable COPD with bronchitis: intra-patient and inter-patient variability. Thorax 2008, 63:493–503.CrossRefPubMed Sapey E, Bayley D, Ahmad A, Newbold P, Snell N, Stockley RA: Inter-relationships between inflammatory markers in patients with stable COPD with bronchitis: intra-patient and inter-patient variability. Thorax 2008, 63:493–503.CrossRefPubMed
25.
go back to reference Bresser P, Out TA, van Alphen L, Jansen HM, Lutter R: Airway inflammation in nonobstructive and obstructive chronic bronchitis with chronic Haemophilus influenzae airway infection. Comparison with noninfected patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000, 162:947–952.CrossRefPubMed Bresser P, Out TA, van Alphen L, Jansen HM, Lutter R: Airway inflammation in nonobstructive and obstructive chronic bronchitis with chronic Haemophilus influenzae airway infection. Comparison with noninfected patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000, 162:947–952.CrossRefPubMed
26.
go back to reference Bresser P, van Alphen L, Habets FJ, Hart AA, Dankert J, Jansen HM, Lutter R: Persisting Haemophilus influenzae strains induce lower levels of interleukin-6 and interleukin-8 in H292 lung epithelial cells than nonpersisting strains. Eur Respir J 1997, 10:2319–2326.CrossRefPubMed Bresser P, van Alphen L, Habets FJ, Hart AA, Dankert J, Jansen HM, Lutter R: Persisting Haemophilus influenzae strains induce lower levels of interleukin-6 and interleukin-8 in H292 lung epithelial cells than nonpersisting strains. Eur Respir J 1997, 10:2319–2326.CrossRefPubMed
27.
go back to reference Sethi S, Sethi R, Eschberger K, Lobbins P, Cai X, Grant BJ, Murphy TF: Airway bacterial concentration and exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007, 176:356–361.CrossRefPubMed Sethi S, Sethi R, Eschberger K, Lobbins P, Cai X, Grant BJ, Murphy TF: Airway bacterial concentration and exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007, 176:356–361.CrossRefPubMed
28.
go back to reference Sethi S, Evans N, Grant BJ, Murphy TF: New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002, 347:465–471.CrossRefPubMed Sethi S, Evans N, Grant BJ, Murphy TF: New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002, 347:465–471.CrossRefPubMed
29.
go back to reference Abusriwil H, Stockley RA: Bacterial load and exacerbations of COPD. Am J Respir Crit Care Med 2008, 177:1048–1049.CrossRefPubMed Abusriwil H, Stockley RA: Bacterial load and exacerbations of COPD. Am J Respir Crit Care Med 2008, 177:1048–1049.CrossRefPubMed
30.
go back to reference Stockley RA, O'Brien C, Pye A, Hill SL: Relationship of sputum colour to nature and outpatient management of acute exacerbations of COPD. Chest 2000, 117:1638–1645.CrossRefPubMed Stockley RA, O'Brien C, Pye A, Hill SL: Relationship of sputum colour to nature and outpatient management of acute exacerbations of COPD. Chest 2000, 117:1638–1645.CrossRefPubMed
31.
go back to reference Soler N, Agustí C, Angrill J, Puig de la Bellacasa J, Torres A: Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease. Thorax 2006, 62:29–35.CrossRefPubMedPubMedCentral Soler N, Agustí C, Angrill J, Puig de la Bellacasa J, Torres A: Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease. Thorax 2006, 62:29–35.CrossRefPubMedPubMedCentral
32.
go back to reference Wilson R: Using antibiotics to delay exacerbations of chronic obstructive pulmonary disease. Hot Topics Respir Dis 2006, 2:21–26. Wilson R: Using antibiotics to delay exacerbations of chronic obstructive pulmonary disease. Hot Topics Respir Dis 2006, 2:21–26.
33.
go back to reference Chodosh S: Clinical significance of the infection-free interval in the management of acute bacterial exacerbations of chronic bronchitis. Chest 2005, 127:2231–226.CrossRefPubMed Chodosh S: Clinical significance of the infection-free interval in the management of acute bacterial exacerbations of chronic bronchitis. Chest 2005, 127:2231–226.CrossRefPubMed
Metadata
Title
Colour of sputum is a marker for bacterial colonisation in chronic obstructive pulmonary disease
Authors
Marc Miravitlles
Alicia Marín
Eduard Monsó
Sara Vilà
Cristian de la Roza
Ramona Hervás
Cristina Esquinas
Marian García
Laura Millares
Josep Morera
Antoni Torres
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2010
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-11-58

Other articles of this Issue 1/2010

Respiratory Research 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine